GL1X · GenesisL1 explorer

MolNFT v1 · #188466 · protein

Human lrh-1 lbd bound to agonist 6N-10CA and fragment of TIF2 coactivator

7TT8 · Nuclear receptor subfamily 5 group a member 2: “Human lrh-1 lbd bound to agonist 6N-10CA and fragment of TIF2 coactivator”. X-ray diffraction, 1 ligand (IUW), 4 pockets (best druggability 0.85). MolNFT v1 #188466 on GenesisL1: 3D…

PDB
7TT8
Type
protein
Length
245 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor subfamily 5 group a member 2; Nuclear receptor coactivator 2
UniProt
O00482, Q15596
Ligands
IUW
Pockets
4 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 72% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor subfamily 5 group a member 2protein23571% helix, 3% strandO00482
CNuclear receptor coactivator 2protein1080% helix, 0% strandQ15596

Ligands and binding sites

  • IUW · 10-[(3aR,6S,6aR)-3-phenyl-3a-(1-phenylethenyl)-6-(sulfamoylamino)-1,3a,4,5,6,6a-hexahydropentalen-2-yl]decanoic acid (non-preferred name) · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14190.850.9235IUW
21340.540.8121empty
3760.340.7514empty
4760.330.7416empty

Interfaces

1 interface between chains.

  • A–C · 561 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 7TT8 · Human LRH-1 LBD bound to agonist 6N-10CA and fragment of Tif2 coactivator · the same entry in another collection · chain A against A, TM-score 1.00
  • O00482 · AlphaFold monomer V2.0 prediction for nuclear receptor subfamily 5 group a member 2… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.